Tower Research Capital (TRC)’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,006
Closed -$430K 6631
2022
Q4
$430K Buy
15,006
+12,473
+492% +$360K 0.02% 784
2022
Q3
$74K Buy
2,533
+1,602
+172% +$36.9K ﹤0.01% 2833
2022
Q2
$13K Sell
931
-6,296
-87% -$88.6K ﹤0.01% 4254
2022
Q1
$132K Buy
7,227
+6,424
+800% +$92.1K ﹤0.01% 2011
2021
Q4
$12K Buy
803
+751
+1,444% +$11.6K ﹤0.01% 4360
2021
Q3
$1K Sell
52
-5,285
-99% -$136K ﹤0.01% 5606
2021
Q2
$162K Sell
5,337
-18
-0.3% -$495 ﹤0.01% 2081
2021
Q1
$157K Buy
+5,355
New +$166K ﹤0.01% 2213

Other funds holding SGFY

Tower Research Capital (TRC)'s SGFY Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 15,006 shares — an estimated $430K sold.

Tower Research Capital (TRC) first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $430K in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 15,006 Signify Health, Inc. shares in Q1 2023, an estimated $430K.
  • Tower Research Capital (TRC) first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Signify Health, Inc. position peaked at $430K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.